Jeffers L, Church D, Basu H, Marton L, Wilding G
Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison 53792-0001, USA.
Cancer Chemother Pharmacol. 1997;40(2):172-9. doi: 10.1007/s002800050643.
Polyamines are biologic cations necessary for normal cell growth. Polyamine analogues have been shown to be effective inhibitors of tumor growth. We tested the effect of the polyamine analogues 1,1 9-bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), N1,N11-bis(ethyl)norspermine (BE-3-3-3) and 1,15-bis(ethylamino)-4,12-diazapentadecane (BE-3-7-3) on the growth of the prostate cancer cell lines DU145, LNCaP and PC-3 in vitro. We also tested the effect of BE-4-4-4-4 on androgen-independent DU145 cells in vivo via a nude mouse xenograft model.
In vitro, cell proliferation was measured using a DNA assay or a colony-formation assay. In vivo, mice were given saline or BE-4-4-4-4 3 mg/kg or 5 mg/kg intraperitoneally twice daily on days 7-10 and 14-17 (cycle 1), days 49-52 and 56-59 (cycle 2) and days 91-94 and 98-101 (cycle 3).
The proliferation of DU145, LNCaP and PC-3 prostate cancer cell lines was inhibited in a dose-dependent manner by BE-4-4-4-4. Intracellular putrescine, spermidine and spermine levels in all three cell lines declined after only 24 h exposure to BE-4-4-4-4 in vitro. Animals receiving BE-4-4-4-4 showed inhibition of tumor growth which continued throughout the experiment with 74% (3 mg/kg) and 81% (5 mg/kg) growth inhibition seen on day 101. No overt toxic reactions besides weight loss were observed in BE-4-4-4-4-treated animals. Tumor tissue from animals treated with BE-4-4-4-4 showed a dose-dependent decrease in spermidine and spermine levels but no decline in putrescine levels as compared with control. BE-4-4-4-4 levels were highest in tumors on day 63 with levels reaching 0.33 and 1.45 nmol/mg protein from animals treated at the 3 mg/kg and 5 mg/kg doses, respectively.
These results show the polyamine analogues BE-4-4-4-4, BE-3-3-3 and BE-3-7-3 to be effective inhibitors of prostate cancer cell growth in vitro and BE-4-4-4-4 to be an effective inhibitor of DU145 cells in vivo with minimal toxicity.
多胺是正常细胞生长所必需的生物阳离子。多胺类似物已被证明是有效的肿瘤生长抑制剂。我们测试了多胺类似物1,19 - 双(乙氨基)- 5,10,15 - 三氮杂十九烷(BE - 4 - 4 - 4 - 4)、N1,N11 - 双(乙基)去甲精胺(BE - 3 - 3 - 3)和1,15 - 双(乙氨基)- 4,12 - 二氮杂十五烷(BE - 3 - 7 - 3)对前列腺癌细胞系DU145、LNCaP和PC - 3体外生长的影响。我们还通过裸鼠异种移植模型测试了BE - 4 - 4 - 4 - 4对雄激素非依赖性DU145细胞体内生长的影响。
在体外,使用DNA测定法或集落形成测定法测量细胞增殖。在体内,于第7 - 10天和14 - 17天(第1周期)、第49 - 52天和56 - 59天(第2周期)以及第91 - 94天和98 - 101天(第3周期),每天两次给小鼠腹腔注射生理盐水或3 mg/kg或5 mg/kg的BE - 4 - 4 - 4 - 4。
BE - 4 - 4 - 4 - 4以剂量依赖性方式抑制DU145、LNCaP和PC - 3前列腺癌细胞系的增殖。在体外仅暴露于BE - 4 - 4 - 4 - 4 24小时后,所有三种细胞系中的细胞内腐胺、亚精胺和精胺水平均下降。接受BE - 4 - 4 - 4 - 4的动物显示出肿瘤生长受到抑制,在整个实验过程中这种抑制持续存在,在第101天观察到74%(3 mg/kg)和81%(5 mg/kg)的生长抑制。在接受BE - 4 - 4 - 4 - 4治疗的动物中,除体重减轻外未观察到明显的毒性反应。与对照组相比,接受BE - 4 - 4 - 4 - 4治疗的动物的肿瘤组织中亚精胺和精胺水平呈剂量依赖性降低,但腐胺水平未下降。在第63天肿瘤中的BE - 4 - 4 - 4 - 4水平最高,来自接受3 mg/kg和5 mg/kg剂量治疗动物的肿瘤中的水平分别达到0.33和1.45 nmol/mg蛋白质。
这些结果表明多胺类似物BE - 4 - 4 - 4 - 4、BE - 3 - 3 - 3和BE - 3 - 7 - 3在体外是前列腺癌细胞生长的有效抑制剂,并且BE - 4 - 4 - 4 - 4在体内是DU145细胞的有效抑制剂,且毒性最小。